← All news
Markets
Verici Dx (LSE:VRCI) lines up a transplant genetic test launch this week: could TranscripTx widen its reach?
Highlights Verici Dx plans to launch TranscripTx before the end of the year. The test uses blood RNA sequencing and AI-assisted gene selection. It will be offered as a laboratory-developed test from Verici's accredited lab. Verici Dx (LSE:V…
Covered by 1 outlet
All coverage · 1 article